Curcumin-artemisinin combination therapy for malaria

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1859-1860

  Nandakumar, Dalavaikodihalli Nanjaiah ^a   Nagaraj, Viswanathan Arun ^a   Vathsala, Palakkod Govindan ^a   Rangarajan, Pundi ^a   Padmanaban, Govindarajan ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTEMISININ; CURCUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG INDICATION; DRUG POTENTIATION; IC 50; IN VITRO STUDY; MALARIA; MONOTHERAPY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CURCUMIN; DRUG THERAPY, COMBINATION; INHIBITORY CONCENTRATION 50; MALARIA; MICE; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; SESQUITERPENES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646445146     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1859-1860.2006     Document Type: Article

References (15)

1. Cheng, A. L., J. K. Hsu, M. Lin, Y. F. Hsu, T. S. Ho, J. Y. Shen, J. T. Ko, B. R. Lin, W. Lin, H. S. Ming-Shiang, et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high risk or premalignant lesion. Anticancer Res. 21:2895-2900.
2. Desjardins, R. E., R. E. Canefield, C. J. Hayness, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
3. Fitch, C. D., R. Chevli, H. S. Banyal, G. Phillips, M. A. Pfaller, and D. J. Krogstad. 1982. Lysis of Plasmodium falciparum by ferriprotoporpyrin IX and chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents Chemother. 21:819-822.
4. International Artemisinin Study Group. 2004. Artesunate combination for treatment of malaria: meta-analysis. Lancet 363:9-17.
5. Jambou, R., E. Legrand, M. Niang, N. Khim, P. Lim, B. Volney, M. T. Ekala, C. Bouchier, P. Esterre, T. Fandeur, and O. Mercereau-Puijalon. 2005. Resistance of Plasmodium falciparum field isolates to in vitro artemeether and point mutations of the SERCA-type PfATPase 6. Lancet 366:1960-1963.
6. Joe, B., M. Vijayakumar, and B. R. Lokesh. 2004. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44:97-111.
7. Johnson, M. D., C. Mac Dougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
8. Kremsner, P. G., and S. Krishna. 2004. Antimalarial combinations. Lancet 364:285-294.
9. Nosten, F. M., M. van Vugt, R. Price, C. Luxemberger, K. L. Thway, A. Brockman, R. McGready, F. ter kuile, S. Looareesuwan, and N. J. White. 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297-302.
10. Reddy, R. C., P. G. Vathsala, V. G. Keshamouni, G. Padmanaban, and P. N. Rangarajan. 2005. Curcumin for malaria therapy. Biochem. Biophys. Res. Commun. 326:472-474.
11. Shoba, G., D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. Srinivas. 1998. Influence of Piperine on the pharmakinetics of curcumin in animals and human volunteers. Planta Med. 64:353-356.
12. ter Kuile, F., N. J. White, P. H. Halloway, G. Pasvol, and S. Krishna. 1993. In vitro studies of the pharmacodynamic properties of drugs used for severe malaria. Exp. Parasitol. 76:85-95.
13. Toovey, S., and A. Jamieson. 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans. R. Soc. Trop. Med. Hyg. 98:261-267.
14. Trager, W., and B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
15. Yeung, S., W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White. 2004. Antimalarial drug resistance, artemisinin-based combination therapy and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 71:179-186.